Kiran Chawla1, Shashidhar Vishwanath2, Ashu Gupta3. 1. Additional Professor, Department of Microbiology, Kasturba Medical College, Manipal University , Manipal, India . 2. Associate Professor, Department of Microbiology, Kasturba Medical College, Manipal University , Manipal, India . 3. Tutor, Department of Microbiology, Kasturba Medical College, Manipal University , Manipal, India .
Abstract
BACKGROUND: Stenotrophomonas maltophilia infection is gaining importance as an important cause of nosocomial pneumonia due to its characteristic inherent resistance to many broad- spectrum antibiotics. In this study we evaluated the demographic, clinical and microbiological profile of patients with lower respiratory tract infection due to Stenotrophomonas maltophilia. MATERIALS AND METHODS: A retrospective analysis of 33 patients diagnosed with Stenotrophomonas maltophilia lower respiratory tract infections during a period of two years from 2012 - 2013 was done. RESULTS: The predominant predisposing factor observed was mechanical ventilation in 17(51.5%) cases. Fluoroquinolones were the most effective antibiotic (26;78.8%) followed by trimethoprim-sulfamethoxazole (24;72.7%). Among the 19 patients treated with proper antibiotic, 13(68.4%) showed clinical improvement. Among the 14 patients who did not receive appropriate antibiotic for Stenotrophomonas maltophilia infection, 8(57.1%) showed improvement. Two (6%) had blood culture positive for Stenotrophomonas maltophilia. Mortality rate was 21.2%. CONCLUSION: Stenotrophomonas maltophilia is emerging as an important nosocomial pathogen with increased risk in patients on mechanical ventilation in ICU. Empiric therapy should include agents active against S.maltophilia such as newer flouroquinolones and trimethoprim-sulfamethoxazole.
BACKGROUND:Stenotrophomonas maltophilia infection is gaining importance as an important cause of nosocomial pneumonia due to its characteristic inherent resistance to many broad- spectrum antibiotics. In this study we evaluated the demographic, clinical and microbiological profile of patients with lower respiratory tract infection due to Stenotrophomonas maltophilia. MATERIALS AND METHODS: A retrospective analysis of 33 patients diagnosed with Stenotrophomonas maltophilia lower respiratory tract infections during a period of two years from 2012 - 2013 was done. RESULTS: The predominant predisposing factor observed was mechanical ventilation in 17(51.5%) cases. Fluoroquinolones were the most effective antibiotic (26;78.8%) followed by trimethoprim-sulfamethoxazole (24;72.7%). Among the 19 patients treated with proper antibiotic, 13(68.4%) showed clinical improvement. Among the 14 patients who did not receive appropriate antibiotic for Stenotrophomonas maltophilia infection, 8(57.1%) showed improvement. Two (6%) had blood culture positive for Stenotrophomonas maltophilia. Mortality rate was 21.2%. CONCLUSION:Stenotrophomonas maltophilia is emerging as an important nosocomial pathogen with increased risk in patients on mechanical ventilation in ICU. Empiric therapy should include agents active against S.maltophilia such as newer flouroquinolones and trimethoprim-sulfamethoxazole.
Entities:
Keywords:
Antimicrobial drug resistance; Quinolones; Stenotrophomonas maltophilia; Trimethoprim-sulfamethoxazole
Authors: Vasanthakumari Neela; Seyedeh Zahra Rouhani Rankouhi; Alex van Belkum; Richard V Goering; Rukman Awang Journal: Int J Infect Dis Date: 2012-06-13 Impact factor: 3.623
Authors: Andrea L H Kwa; Jenny G H Low; Tze Peng Lim; Pay Chin Leow; Asok Kurup; Vincent H Tam Journal: Ann Acad Med Singapore Date: 2008-10 Impact factor: 2.473
Authors: Mark A Toleman; Peter M Bennett; David M C Bennett; Ronald N Jones; Timothy R Walsh Journal: Emerg Infect Dis Date: 2007-04 Impact factor: 6.883
Authors: Emanuela Roscetto; Laura Vitiello; Rosa Muoio; Amata A Soriano; Vita D Iula; Antonio Vollaro; Eliana De Gregorio; Maria R Catania Journal: Front Microbiol Date: 2015-07-16 Impact factor: 5.640
Authors: Ifey Alio; Mirja Gudzuhn; Pablo Pérez García; Dominik Danso; Marie Charlotte Schoelmerich; Uwe Mamat; Ulrich E Schaible; Jörg Steinmann; Daniel Yero; Isidre Gibert; Thomas A Kohl; Stefan Niemann; Matthias I Gröschel; Johanna Haerdter; Thomas Hackl; Christel Vollstedt; Mechthild Bömeke; Richard Egelkamp; Rolf Daniel; Anja Poehlein; Wolfgang R Streit Journal: Appl Environ Microbiol Date: 2020-11-24 Impact factor: 4.792